Metastatic Cancer Clinical Trials
- A Study of Two Different Dosing Regimens of Capecitabine in Combo with Intravenous Docetaxel (Q3W) in Patients with Locally Advanced and/or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00077857 - Recruiting
Metastatic breast cancer; Metastatic Colorectal Cancer
- A 2x2 (4-way) study of capecitabine in combo w/ oxaliplatin (XELOX) w/ or w/out bevacizumab vs. fluorouracil/leucovorin w/ oxaliplatin (FOLFOX-4) w/ or w/out bevacizumab as first-line treatment for pts w/ metastatic colorectal cancer
ClinicalTrials.gov Identifier: NCT00069095 - Active, not recruiting
Metastatic Colorectal Cancer
- A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
ClinicalTrials.gov Identifier: NCT00439179 - Active, not recruiting
Metastatic Pancreatic Cancer
- Paclitaxel With Or Without GW572016 As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075270 - Active, not recruiting
Metastatic breast cancer
- A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00274469 - Active, not recruiting
Metastatic Breast Cancer
- GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
Metastatic Colorectal Cancer
- Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00148070 - Active, not recruiting
Metastatic breast cancer
- Phase II Letrozole + Herceptin in Her2neu Positive, ER and/or PR Receptor (+),Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00134680 - Active, not recruiting
Metastatic breast cancer
- Cetuximab Combined with Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
ClinicalTrials.gov Identifier: NCT00154102 - Active, not recruiting
EGFR-expressing metastatic colorectal cancer
- GW572016 For Treatment Of Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00062686 - Active, not recruiting
Metastatic breast cancer
- Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women with Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00156273 - Recruiting
Metastatic breast cancer
- Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
ClinicalTrials.gov Identifier: NCT00093444 - Active, not recruiting
Liver Cancer; Metastatic Cancer
- Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
ClinicalTrials.gov Identifier: NCT00216060 - Active, not recruiting
Metastatic Prostate Cancer
- A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-Line Treatment of Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00251472 - Active, not recruiting
Metastatic Breast Cancer
- Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00073528 - Active, not recruiting
Metastatic breast cancer; Advanced Breast Cancer
- Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
ClinicalTrials.gov Identifier: NCT00411450 - Recruiting
Colon Cancer; Colorectal Cancer; Rectal Cancer; Cancer; Metastatic Cancer; Metastatic Colorectal Cancer; Oncology
- Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
ClinicalTrials.gov Identifier: NCT00550654 - Recruiting
Kidney Cancer; Melanoma (Skin); Metastatic Cancer; Ovarian Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
- Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
ClinicalTrials.gov Identifier: NCT00262067 - Active, not recruiting
Metastatic Breast Cancer
- Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00364754 - Active, not recruiting
Metastatic/Recurrent Breast Cancer
- Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00244868 - Active, not recruiting
Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00146042 - Active, not recruiting
HER-2 Positive Metastatic Breast Cancer
- A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00191984 - Active, not recruiting
Metastatic Colorectal Cancer
- Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00316199 - Active, not recruiting
Metastatic Breast Cancer
- GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00320411 - Active, not recruiting
Metastatic Breast Cancer
- Her-2/Neu in Patients with Metastatic Breast Cancer (AdHERe)
ClinicalTrials.gov Identifier: NCT00162929 - Recruiting
Metastatic breast cancer
- Capecitabine(Xeloda) With Or Without Lapatinib(GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00078572 - Active, not recruiting
Advanced Breast Cancer; Metastatic breast cancer
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00214864 - Active, not recruiting
Metastatic Breast Cancer
- Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00334802 - Active, not recruiting
Metastatic Breast Cancer
- Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00286130 - Active, not recruiting
Metastatic Colorectal Cancer
- Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
ClinicalTrials.gov Identifier: NCT00019604 - Recruiting
Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00554918 - Recruiting
Metastatic Cancer; Prostate Cancer
- Satraplatin for Patients With Metastatic Breast Cancer (MBC)
ClinicalTrials.gov Identifier: NCT00265655 - Active, not recruiting
Metastatic Breast Cancer
- Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00524810 - Active, not recruiting
Metastatic Breast Cancer
- Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer
ClinicalTrials.gov Identifier: NCT00414492 - Recruiting
Metastatic Colorectal Cancer
- Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
ClinicalTrials.gov Identifier: NCT00082927 - Recruiting
Breast Cancer; Lung Cancer; metastatic cancer; Pain; Prostate Cancer
- Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00320385 - Active, not recruiting
Metastatic Breast Cancer
- Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00140738 - Recruiting
Metastatic breast cancer
- AN OPEN-LABEL PHASE I STUDY OF WEEKLY ABI-007 AND VINORELBINE WITH OR WITHOUT G-CSF IN PATIENTS WITH STAGE IV (METASTATIC) BREAST CANCER
ClinicalTrials.gov Identifier: NCT00140140 - Active, not recruiting
Stage IV (Metastatic) Breast Cancer
- Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00225758 - Recruiting
Metastatic breast cancer
- SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00270413 - Recruiting
Metastatic Breast Cancer
- Cellular Immune Augmentation in Colon and Rectal Cancer
ClinicalTrials.gov Identifier: NCT00257322 - Active, not recruiting
Metastatic Colon Cancer; Metastatic Rectal Cancer
- Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
ClinicalTrials.gov Identifier: NCT00436735 - Recruiting
Colorectal Cancer; Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neuroendocrine Carcinoma of the Skin; Ovarian Cancer; Pheochromocytoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
- Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00532740 - Recruiting
Liver Cancer; Metastatic Cancer
- Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
ClinicalTrials.gov Identifier: NCT00019513 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Lymphoma; Pancreatic Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00387907 - Recruiting
Advanced Breast Cancer; Breast Cancer; Metastatic Breast Cancer
- A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)
ClinicalTrials.gov Identifier: NCT00399802 - Active, not recruiting
Breast Cancer; Metastatic Bone Disease
- Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
ClinicalTrials.gov Identifier: NCT00268918 - Active, not recruiting
Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer
- Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
ClinicalTrials.gov Identifier: NCT00452140 - Recruiting
Metastatic Breast Cancer; Advanced Breast Cancer
- Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
ClinicalTrials.gov Identifier: NCT00522457 - Recruiting
Metastatic Breast Cancer; Advanced Breast Cancer
- Evaluate Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus, NV1020, to Treat Colorectal Cancer Metastatic to Liver.
ClinicalTrials.gov Identifier: NCT00149396 - Recruiting
Colorectal cancer metastatic to the liver
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
ClinicalTrials.gov Identifier: NCT00544804 - Recruiting
Breast Cancer; Metastatic Cancer
- Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00068237 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; metastatic squamous neck cancer with occult primary; ...
- Companion Pharmacogenetic Study to UMCC 9900/9901
ClinicalTrials.gov Identifier: NCT00146029 - Active, not recruiting
Metastatic breast cancer; Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)
- SPIRITT - Q2W FOLFIRI Regimen Plus Panitumumab or a Q2W FOLFIRI Regimen Plus Bevacizumab for 2nd-Line mCRC
ClinicalTrials.gov Identifier: NCT00418938 - Recruiting
Cancer; Colon Cancer; Colorectal Cancer; Metastatic Cancer; Rectal Cancer; Metastatic Colorectal Cancer
- Biological Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
- Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
ClinicalTrials.gov Identifier: NCT00392938 - Recruiting
Metastatic Cancer; Prostate Cancer
- Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00250874 - Recruiting
Metastatic Breast Cancer
- A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
ClinicalTrials.gov Identifier: NCT00281697 - Recruiting
Metastatic Breast Cancer
- Phase II Trial of Capecitabine Plus Fulvestrant in First Line Treatment of Hormone Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00534417 - Recruiting
Metastatic Breast Cancer
- A Phase I Study to Assess the Safety and Distribution of GT-111 in Patients With Advanced Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00559117 - Recruiting
Advanced and/or Metastatic Solid Organ Cancer
- The Study of Avastin® to Reverse AEI in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy
ClinicalTrials.gov Identifier: NCT00240071 - Recruiting
Metastatic Breast Cancer
- Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00303615 - Recruiting
Metastatic Breast Cancer
- A Study Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
ClinicalTrials.gov Identifier: NCT00434356 - Recruiting
Metastatic Breast Cancer
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00467012 - Recruiting
Metastatic Breast Cancer
- A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00509769 - Recruiting
Metastatic Breast Cancer
- Phase II Study of Ironotecan Plus Capecitabine in Patients With Antracycline and Taxane Pretreated Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00532714 - Recruiting
Breast Cancer Metastatic
- E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes and Refractory to the Most Recent Chemotherapy
ClinicalTrials.gov Identifier: NCT00337103 - Recruiting
Metastatic Breast Cancer
- PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
ClinicalTrials.gov Identifier: NCT00364013 - Recruiting
Metastatic Colorectal Cancer
- Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00422773 - Recruiting
Metastatic Colorectal Cancer
- A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00454532 - Recruiting
Metastatic Breast Cancer
- A Phase I/II Study of AZD2171 in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
ClinicalTrials.gov Identifier: NCT00494221 - Recruiting
Metastatic Colorectal Cancer
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00254137 - Active, not recruiting
Metastatic Colorectal Cancer
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
- Tox/Benefit Ratio Optimization of Chemotherapy in CRC Patient by Determination of Individual Genotypic Determinants.
ClinicalTrials.gov Identifier: NCT00138060 - Recruiting
Metastatic Colorectal Cancer
- Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00171847 - Recruiting
Metastatic Breast Cancer
- GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00251433 - Recruiting
Metastatic Breast Cancer
- Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00367250 - Recruiting
Metastatic Breast Cancer
- A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00383149 - Recruiting
Metastatic Pancreatic Cancer
- Cediranib (AZD2171, RECENTINtm) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00399035 - Recruiting
Metastatic Colorectal Cancer
- Safety of Everolimus in Combination Therapy, in Patients With HER2-Overexpressing Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00426556 - Recruiting
Metastatic Breast Cancer
- Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00444041 - Recruiting
Metastatic Colorectal Cancer
- Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00459901 - Recruiting
Metastatic Colorectal Cancer
- A Phase I Study of CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00270907 - Recruiting
Metastatic Breast Cancer; Breast Cancer
- Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)
ClinicalTrials.gov Identifier: NCT00307229 - Recruiting
Metastatic Breast Cancer; Recurrent Breast Cancer
- Circulating Tumor Cells in Patients with Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00133913 - Active, not recruiting
Metastatic Colorectal Cancer
- Clinical Trial in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00235898 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer
ClinicalTrials.gov Identifier: NCT00103038 - Active, not recruiting
Brain Tumor; Breast Cancer; Lung Cancer; Lymphoma; metastatic cancer
- Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00222469 - Recruiting
Metastatic Pancreatic Cancer
- ErbB2 Over-Expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
ClinicalTrials.gov Identifier: NCT00272987 - Recruiting
Metastatic Breast Cancer
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00288249 - Recruiting
Metastatic Breast Cancer
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00436410 - Recruiting
Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Kidney Cancer; Liver Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer
- Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003133 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
- Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00525096 - Active, not recruiting
Metastatic Breast Cancer
- The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00444054 - Recruiting
Cancer; Breast Cancer; Colon Cancer; Cervical Cancer; Uterine Cancer; Ovarian Cancer
- Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
ClinicalTrials.gov Identifier: NCT00281658 - Recruiting
Metastatic Breast Cancer
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00394082 - Recruiting
Metastatic Breast Cancer
- Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00439270 - Recruiting
Metastatic Prostate Cancer
- Phase II Study of Lapatinib and Bevacizumab for Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00444535 - Recruiting
Metastatic Breast Cancer
- BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00447122 - Recruiting
Metastatic Pancreatic Cancer
- Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer.
ClinicalTrials.gov Identifier: NCT00477464 - Recruiting
Metastatic Breast Cancer
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
